Cluster annotations include lipid species (clusters 16), amino acids (AA
Retatrutide, an investigational triple GIP, GLP-1, and glucagon receptor agonist, has produced substantial weight loss in phase 2 obesity trials and promising topline phase 3 results
At the time, the FDA presented a lot of adverse event data that showed there was a risk of immunogenicity immune reactions and that raised some red flags for the committee, said Gupta, an adjunct assistant professor of anesthesiology at the Johns Hopkins University School of Medicine
However, when co-administered with GLP-1R and GIPR agonism, the insulin-stimulating effects of those two pathways offset the glucagonergic glucose-raising action, while the lipolytic and thermogenic benefits of glucagon receptor signalling are preserved [3]
Mounjaro is approved for type 2 diabetes but has superior weight loss effects due to its dual action on GIP and GLP-1 receptors